Takeda

News

Takeda strikes three new immuno-oncology deals

Takeda is upping its commitment to cancer after its Shire takeover with the announcement of three new research collaborations in immuno-oncology.

News

Eisai, Takeda and GARDP hunt for new antibiotics

The not-for-profit Global Antibiotic Research and Development Partnership has joined forces with Eisai and Takeda to search for new antibiotics.

News

Shareholders approve Takeda's $59bn takeover of Shire

Takeda’s $59 billion acquisition of Shire has been backed by shareholders from both companies, clearing the way for the deal to close early next year.

News

Takeda must sell gastro drug to merge with Shire - EU regula...

European regulators have officially rubber stamped Takeda’s $62 billion takeover of Shire, although the merged company will have to sell off a pipeline clinical trial drug for inflammatory

News

Takeda hurries $62bn Shire acquisition, calls investor vote ...

Takeda will hold an investor vote on its $62 billion acquisition of Shire next month, and aims to close the deal on January 8.

News

Takeda CEO confident about Shire merger

Takeda’s CEO has said he is confident that its $62 billion acquisition of Shire will go ahead, despite a rebellion from a dissident group of shareholders.

Takeda strikes three new immuno-oncology deals

Eisai, Takeda and GARDP hunt for new antibiotics

Shareholders approve Takeda's $59bn takeover of Shire

Takeda must sell gastro drug to merge with Shire - EU regula...

Takeda hurries $62bn Shire acquisition, calls investor vote ...

Takeda CEO confident about Shire merger

Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer

Discover a new era of healthcare panel engagement: Grounded ...

Takeda

Editor's Picks